Merits of a new drug trial for ALS?
Beghi
Ettore
E
Bendotti
Caterina
C
Mennini
Tiziana
T
D027322:Amino Acid Transport System X-AG / Q000096:biosynthesis; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001692:Biological Transport / Q000187:drug effects; D002443:Ceftriaxone / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D051381:Rats; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism
D027322:Amino Acid Transport System X-AG; D000900:Anti-Bacterial Agents; D018698:Glutamic Acid; D002443:Ceftriaxone